MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 356.613
NA - Nord America 18.051
AS - Asia 2.367
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 15
OC - Oceania 13
SA - Sud America 8
Totale 377.088
Nazione #
IT - Italia 351.900
US - Stati Uniti d'America 17.933
CN - Cina 1.847
UA - Ucraina 1.819
SE - Svezia 1.019
GB - Regno Unito 547
FI - Finlandia 470
DE - Germania 466
SG - Singapore 326
FR - Francia 176
CA - Canada 114
IN - India 53
BE - Belgio 41
NL - Olanda 41
VN - Vietnam 41
RU - Federazione Russa 36
KR - Corea 32
EU - Europa 21
ES - Italia 18
CZ - Repubblica Ceca 17
IR - Iran 17
IL - Israele 15
AU - Australia 11
RO - Romania 9
BR - Brasile 8
MU - Mauritius 8
TR - Turchia 8
CH - Svizzera 7
AT - Austria 6
IE - Irlanda 6
JP - Giappone 6
AL - Albania 5
MX - Messico 4
PL - Polonia 4
ZA - Sudafrica 4
HK - Hong Kong 3
HR - Croazia 3
LU - Lussemburgo 3
NO - Norvegia 3
PT - Portogallo 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DK - Danimarca 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
DZ - Algeria 1
GR - Grecia 1
ID - Indonesia 1
KH - Cambogia 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TW - Taiwan 1
Totale 377.088
Città #
Cagliari 350.828
Fairfield 2.579
Woodbridge 2.181
Chandler 1.570
Houston 1.433
Ashburn 1.361
Wilmington 1.146
Ann Arbor 1.055
Seattle 1.007
Jacksonville 900
Cambridge 861
Nyköping 722
Dearborn 400
Nanjing 351
Boardman 308
Beijing 253
Boston 233
Shanghai 200
New York 190
Helsinki 183
Milan 147
San Diego 133
Singapore 127
Shenyang 126
Nanchang 105
Toronto 92
Hebei 91
Redwood City 90
Guangzhou 87
Jiaxing 86
Norwalk 83
Verona 79
Changsha 75
Washington 59
London 58
Sassari 56
Tianjin 48
Mountain View 46
Jinan 42
Dong Ket 40
Zhengzhou 40
Ningbo 37
Hangzhou 36
Los Angeles 36
Atlanta 34
Auburn Hills 32
Brussels 31
Orange 30
Hefei 27
Kunming 27
Pune 26
Taizhou 26
Seoul 24
Rome 23
Falls Church 18
Millbury 16
Phoenix 15
Wuhan 14
Chicago 13
Edinburgh 13
Borås 12
Saint Petersburg 12
Brno 11
Indiana 11
Amsterdam 10
Augusta 10
Domusnovas 10
Kilburn 10
Redmond 10
Fuzhou 9
Detroit 8
Leawood 8
Madrid 8
Palermo 7
San Mateo 7
Stockholm 7
Ardabil 6
Chengdu 6
Chiswick 6
Meana Sardo 6
Nürnberg 6
Perth 6
San Francisco 6
Simi Valley 6
Tel Aviv 6
Wuxi 6
Baotou 5
Dublin 5
Florence 5
Fremont 5
Haikou 5
Hounslow 5
Jinhua 5
Munich 5
New Bedfont 5
Parma 5
Shenzhen 5
Trieste 5
Wandsworth 5
Acton 4
Totale 370.228
Nome #
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.686
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.143
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.080
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.067
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 3.990
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 3.931
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 3.786
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.751
Overexpression of the cytokine BAFF and autoimmunity risk 3.599
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.562
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.540
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.523
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.500
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 3.497
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.494
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.432
Walking improvements with nabiximols in patients with multiple sclerosis 3.356
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.344
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.274
The burden of multiple sclerosis variants in continental Italians and Sardinians 3.252
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.252
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.247
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.232
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.227
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.185
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.147
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.079
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 3.044
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 3.033
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.027
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.025
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 2.964
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 2.874
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 2.789
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.783
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.780
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 2.779
Influence of treatments in multiple sclerosis disability: a cohort study 2.751
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 2.739
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 2.731
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. 2.697
Refining the connection between gait and cognition: training the body to improve the brain 2.662
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 2.652
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.646
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.629
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.547
Factors influencing MS outcome in Sardinia: a clinical and genetic study 2.533
Oral agents in multiple sclerosis 2.505
Perception of risk and shared decision making process in multiple sclerosis 2.488
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.478
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.447
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.427
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.423
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.409
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.408
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.382
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.378
Impact of the media on future hope in multiple sclerosis 2.369
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.310
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.305
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.288
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.255
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 2.184
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.156
The cohort of the multiple sclerosis center of Cagliari 2.147
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.127
Induction and escalation therapies in multiple sclerosis 2.079
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.054
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.030
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.005
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 1.974
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 1.970
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 1.934
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 1.925
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 1.907
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 1.869
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 1.868
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 1.865
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.834
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 1.822
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 1.815
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.806
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.799
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.789
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.776
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.773
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 1.752
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.747
The Italian multiple sclerosis register 1.741
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 1.736
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 1.691
The risk of bipolar disorders in multiple sclerosis 1.691
null 1.641
Facial synkinesis as a first symptom of multiple sclerosis 1.628
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 1.618
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 1.605
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.575
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.565
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.556
Bias in parental transmission of the HLA-DR3 allele in Sardinian multiple sclerosis 1.539
Totale 258.326
Categoria #
all - tutte 455.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 455.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073.833 3.985 2.294 457 1.677 26.408 17.116 9.711 2.521 1.587 1.753 1.716 4.608
2020/2021105.907 3.083 4.062 4.857 24.794 19.140 13.273 9.905 7.691 3.352 6.296 5.866 3.588
2021/202219.556 2.607 1.488 880 1.633 1.641 1.192 889 965 1.828 1.971 2.385 2.077
2022/202325.350 2.402 3.590 3.378 2.013 1.979 2.639 1.023 2.262 1.502 1.567 1.827 1.168
2023/202425.660 1.721 1.382 921 1.912 2.647 4.002 2.760 2.239 1.272 2.171 2.484 2.149
2024/20256.155 6.155 0 0 0 0 0 0 0 0 0 0 0
Totale 377.825